{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibbobyojdyohmxsj5p24f2ey23qtczmw2fhnddlli5vpgnxktnmny",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhum5qttmut2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreics6aihkajctpctirfq2hootxwvhvx2oucuvstvpln2v4txjly6xu"
    },
    "mimeType": "image/jpeg",
    "size": 77580
  },
  "path": "/pharmalot/2026/03/24/fda-slams-soon-shiong-immunitybio-false-misleading-claims/?utm_campaign=rss",
  "publishedAt": "2026-03-24T15:59:32.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Pharmalot",
    "biotechnology",
    "Cancer",
    "FDA",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "Patrick Soon-Shiong, a controversial figure in the biotech industry, was accused by the FDA of making 'false and misleading' claims about a cancer treatment.",
  "title": "STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug",
  "updatedAt": "2026-03-24T16:46:09.000Z"
}